[PDF][PDF] Organoid modeling of the tumor immune microenvironment

…, J Ju, IH Liu, SH Chiou, AA Salahudeen, AR Smith… - Cell, 2018 - cell.com
In vitro cancer cultures, including three-dimensional organoids, typically contain exclusively
neoplastic epithelium but require artificial reconstitution to recapitulate the tumor …

[PDF][PDF] An expanded universe of cancer targets

…, SE Kurtz, A Agarwal, J Brown, K Watanabe-Smith… - Cell, 2021 - cell.com
The characterization of cancer genomes has provided insight into somatically altered genes
across tumors, transformed our understanding of cancer biology, and enabled tailoring of …

[HTML][HTML] Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression

AR Smith, RT Marquez, WC Tsao, S Pathak, A Roy… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Stem cell marker, Musashi-1 (MSI1) is over-expressed in many cancer types; however the
molecular mechanisms involved in MSI1 over-expression are not well understood. We …

[HTML][HTML] Natural product (−)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1

L Lan, C Appelman, AR Smith, J Yu, S Larsen… - Molecular …, 2015 - Elsevier
Musashi-1 (MSI1) is an RNA-binding protein that acts as a translation activator or repressor
of target mRNAs. The best-characterized MSI1 target is Numb mRNA, whose encoded …

Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins

L Lan, H Liu, AR Smith, C Appelman, J Yu, S Larsen… - BMC cancer, 2018 - Springer
Background The Musashi (MSI) family of RNA-binding proteins is best known for the role in
post-transcriptional regulation of target mRNAs. Elevated MSI1 levels in a variety of human …

[PDF][PDF] CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

…, E Baldelli, MB Ryan, S Li, J Peterson, AR Smith… - Cell reports, 2021 - cell.com
We apply genetic screens to delineate modulators of KRAS mutant pancreatic ductal
adenocarcinoma (PDAC) sensitivity to ERK inhibitor treatment, and we identify components of the …

MicroRNA‐383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression

J Li, AR Smith, RT Marquez, J Li, K Li… - Molecular …, 2018 - Wiley Online Library
CREPT (Cell‐cycle‐related and expression‐elevated protein in tumor)/RPRD1B, a novel
protein that enhances the transcription of Cyclin D1 to promote cell proliferation during …

Complete remission of widely metastatic human epidermal growth factor receptor 2–amplified pancreatic adenocarcinoma after precision immune and targeted …

DA King, AR Smith, G Pineda, M Nakano… - JCO Precision …, 2023 - ascopubs.org
Pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest of all human
cancers, 1 compelling discovery of new predictive biomarkers and tailored therapies for this …

Visualization of annular gap junction vesicle processing: the interplay between annular gap junctions and mitochondria

CL Bell, TI Shakespeare, AR Smith… - International journal of …, 2018 - mdpi.com
It is becoming clear that in addition to gap junctions playing a role in cell–cell communication,
gap junction proteins (connexins) located in cytoplasmic compartments may have other …

Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy

KJ Fogle, AR Smith, SL Satterfield, AC Gutierrez… - Molecular genetics and …, 2019 - Elsevier
Seizures are a feature not only of the many forms of epilepsy, but also of global metabolic
diseases such as mitochondrial encephalomyopathy (ME) and glycolytic enzymopathy (GE). …